🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: CHF 1535 pMDI

Found 23 matching trials

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

PHASE2

The purpose of this study is to evaluate the efficacy of Fixed Combination ...

Status

Completed

Location

Medical Center Convex EOOD

Start Date

2018-06-15

Trial ID

NCT03590379

Treatments Being Tested

CHF 5993 DPI CHF5993 pMDI CHF 1535 pMDI Placebo DPI Placebo pMDI

A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

PHASE3

Compare the superiority of CHF 1535 versus CHF 718 in subjects with asthma ...

Status

Completed

Location

Chiesi Clinical Trial Site 840858

Start Date

2022-08-31

Trial ID

NCT05292586

Treatments Being Tested

Beclomethasone Dipropionate/Formoterol Fumarate Beclomethasone Dipropionate

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

PHASE2

The aim of this exploratory investigation is to evaluate if the Forced Expi...

Status

Completed

Location

Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Street Medical Centre

Start Date

2008-02

Trial ID

NCT01343745

Treatments Being Tested

BDP/formoterol BDP/formoterol Placebo

Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma

PHASE3

Efficacy and tolerability of the fixed combination Beclomethasone Dipropion...

Status

Completed

Location

Multiple Locations

Start Date

2004-08

Trial ID

NCT00862264

Treatments Being Tested

Fixed combination Beclomethasone Dipropionate/Formoterol HFA 134a-pMDI

Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients

PHASE3

Primary objective To show the superiority of CHF 1535 (BDP/FF) pMDI (800/2...

Status

Completed

Location

Chiesi Clinical Trial Site

Start Date

2012-04-20

Trial ID

NCT01577082

Treatments Being Tested

CHF1535 200/6 µg pMDI BDP HFA 100 µg pMDI

Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children

PHASE3

This is a single centre, double-blind, double-dummy, randomised, single-cen...

Status

Completed

Location

BørneAstmaKlinikken

Start Date

2011-09

Trial ID

NCT01450774

Treatments Being Tested

CHF 1535 50/6µg beclomethasone dipropionate 50µg + formoterol fumarate 6µg

Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA

PHASE4

The purpose of this phase IV Study is to compare the efficacy of CHF5993 (B...

Status

Terminated

Location

Simplex Kft

Start Date

2022-02-25

Trial ID

NCT05018598

Treatments Being Tested

Administration via pressurized metered dose inhaler (pMDI)Administration via pressurized metered dose inhaler (pMDI)

Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children

PHASE2

The purpose of this clinical study is to compare the improvement in breathi...

Status

Completed

Location

Poradnia Alergologiczna

Start Date

2011-12

Trial ID

NCT01584492

Treatments Being Tested

beclomethasone+formoterol 50/6 (1 inhalation)CHF 1535 50/6 (2 inhalations)CHF 1535 50/6 (4 inhalations)Formoterol + Beclomethasone dipropionate Placebo (6 inhalations)

A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients

PHASE2

The study aim is to compare the pharmacodynamic effects (cardiovascular eff...

Status

Completed

Location

Medicine Evaluation Unit

Start Date

2013-12

Trial ID

NCT02000609

Treatments Being Tested

CHF 1535 NEXThaler 800/48 CHF 1535 NEXThaler 200/12 CHF 1535 NEXThaler PLACEBO CHF 1535 pMDI 200/12 CHF1535 pMDI 800/48

A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma

PHASE3

To demonstrate that CHF 1535 via NEXT DPI (beclomethasone dipropionate + fo...

Status

Completed

Location

Oliver Kornmann - National Coordinator in Germany

Start Date

2009-02

Trial ID

NCT00862394

Treatments Being Tested

BDP/Formoterol Next DPI Foster BDP/Formoterol Next DPI Foster

Previous Next